3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasm Metastasis
9
Colorectal Neoplasms
7
Rectal Neoplasms
5
Colorectal Cancer Metastatic
5
Ovarian Neoplasms
4
Neoplasms
4
Lung Neoplasms
3
Colonic Neoplasms
3
Uveal Melanoma
2
Melanoma
2
Fallopian Tube Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Somatostatinoma
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neurofibromatosis 2
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Macular Degeneration
1
Interventions
pembrolizumab
8
Nivolumab
5
avelumab
4
Ipilimumab
4
Radiotherapy
2
Radiosurgery
2
ALT-803
2
tremelimumab
1
talimogene laherparepvec
1
sapanisertib
1
prednylidene
1
poly ICLC
1
lenvatinib
1
interferon gamma-1b
1
epacadostat
1
efineptakin alfa
1
durvalumab
1
deltacortene
1
cemiplimab
1
cabozantinib
1
bempegaldesleukin
1
atezolizumab
1
Tacrolimus
1
Radiation Dose Hypofractionation
1
Radiation
1
Prednisone
1
Interferon-gamma
1
Interferon-beta
1
CTLA-4 Antigen
1
B7-H1 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Merkel Cell
×
aflibercept
×
Clear all
No trials found.